Everything below concerns somatotroph. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-08-08. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH analog, not a steroid |
| Backbone length | 29 amino acids | Based on GRF(1-29) |
| Substitutions | Four positions | D-Ala2, Gln8, Ala15, Leu27 |
| Appearance | White to off-white powder | Typical lyophilized research material |
| Common synonyms | Modified GRF(1-29) | Usage varies between sources |
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
Laboratory handling centers on minimizing exposure to water, heat and oxygen before use. Working solutions are typically prepared in sterile water or a mild buffer, and any residual particulate matter is removed by filtration. When the powder dissolves slowly, a small proportion of acetonitrile or dilute acetic acid is sometimes added as a co-solvent. Containers are kept sealed and desiccated between uses. Records of lot number, reconstitution date and storage conditions support later comparison of results across experiments.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
According to the Iraqi minutes from the meeting, examined in 2006 by the Parliamentary Commissioner for Standards Sir Philip Mawer and dismissed by Galloway as forgeries, Tariq Aziz, Naji Sabri and Saddam's personal secretary Abid Hamid Mahmud were in attendance as Galloway offered Saddam British staff to launch an English-language Iraqi satellite television channel, and said oil prices were having an impact on the income of the Mariam Appeal. In a radio interview given on the day following the discussion, Galloway said the Iraqi president was determined to show that his offer of readmitting the United Nations weapons inspectors into the country was sincere. Galloway said that the United States had nothing to lose by postponing its plans for invasion. In an 11 August article for The Mail on Sunday, Galloway wrote that Saddam "clearly understood that Iraq has to be seen to go the extra diplomatic mile" and that he expressed fondness for "everything quintessentially British". The piece was interpreted by the CNN as "the latest apparent charm offensive adopted by the Iraqi leader in the face of possible military action against it", and the British Foreign Office refused to consider the overtures. On 12 August, the Iraqi minister of information Muhammad Saeed al-Sahhaf rejected the return of the UN inspectors. In January 2003, Galloway met with Saddam Hussein and Tariq Aziz once more. His claim that the encounter was held in an underground bunker was later contradicted by the Iraqi president's interpreter.
Nuevas Ideas retained its Legislative Assembly supermajority and, with its allies, won 43 of the country's 44 municipalities. Several news outlets described the election results as a "landslide victory" for Bukele and Nuevas Ideas, and Bukele described his victory as "the record in the entire democratic history of the world". The TSE granted Bukele his presidential credentials on 29 February and his second term began on 1 June. In a 2024 interview with Time, Bukele declined to run for a third term in the next presidential election. In July 2025, the Legislative Assembly passed several constitutional amendments, among them, the abolition of presidential term limits that made Bukele eligible to run for re-election indefinitely. Additionally, the legislature voted to move the date of the next presidential election from 2029 to 2027, reducing the length of Bukele's second term by two years. In December 2025, Bukele told YouTuber TheGrefg that "if it were up to me, I would stay for 10 more years". On 28 June 2026, Bukele registered as a pre-candidate with Nuevas Ideas, seeking a third presidential term; on 12 July, the party formally nominated him as its presidential candidate.
Half-Life 2: Episode One is a 2006 first-person shooter game developed and published by Valve for Windows. It continues the story of Half-Life 2 (2004). As the scientist Gordon Freeman, players must escape City 17 with Gordon's companion Alyx Vance. Like previous Half-Life games, Episode One combines shooting, puzzles and storytelling. After the six-year development of Half-Life 2, Valve switched to episodic development, planning to release games more frequently. They focused on developing the character of Alyx and expanded her artificial intelligence. Episode One uses an updated version of Valve's Source engine, with new lighting and animation technology. Episode One received mostly positive reviews; the co-operative gameplay with Alyx received particular praise, although the short length was criticized. It was ported to Xbox 360 and PlayStation 3 as part of the 2007 compilation The Orange Box. Episode Two followed in 2007.
==== Rapid exchange ==== Hydrogen atoms easily separate from electronegative bonds such as hydroxyl bonds (O–H), nitrogen bonds (N–H), and thiol/mercapto bonds (S–H) on hour to day long timescales. This rapid exchange is particularly problematic for measurements of bulk organic matter with these functional groups because isotope compositions are more likely to reflect the source water and not the isotope effect. Therefore, records of paleoclimate that are not measuring ancient waters, rely on other isotopic markers. Advancements in the 1990s held promising potential to resolve this problem: samples were equilibrated with two variations of heavy water and compared. Their ratios represent an exchange factor that can calibrate measurements to correct for H/2H swapping.
Sources: en.wikipedia.org
=== Filters === By 1959, Millipore made porous membrane filters of cellulose esters or other materials which resembled paper in sheet form, and were brittle when dry but friable when wet. Filters consisted of nitrocellulose or polycarbonate membrane nucleopore filters ranging from pore size of 0.2 μm (micrometer) to 20 μm. Modern filters are polyvinylidene fluoride and/or polypropylene based.
A problem with resonant cavities is that a high finesse cavity has very narrow cavity modes, often in the low kHz range (the width of the cavity modes is given by FSR/F, where FSR is the free-spectral range of the cavity, which is given by c/2L, where c is the speed of light and L is the cavity length). Since cw lasers often have free-running linewidths in the MHz range, and pulsed even larger, it is non-trivial to couple laser light effectively into a high finesse cavity. The most important resonant CEAS techniques are cavity ring-down spectrometry (CRDS), integrated cavity output spectroscopy (ICOS) or cavity enhanced absorption spectroscopy (CEAS), phase-shift cavity ring-down spectroscopy (PS-CRDS) and Continuous wave Cavity Enhanced Absorption Spectrometry (cw-CEAS), either with optical locking, referred to as (OF-CEAS), as has been demonstrated Romanini et al. or by electronic locking., as for example is done in the Noise-Immune Cavity-Enhanced Optical-Heterodyne Molecular Spectroscopy (NICE-OHMS) technique. or combination of frequency modulation and optical feedback locking CEAS, referred to as (FM-OF-CEAS). The most important non-resonant CEAS techniques are off-axis ICOS (OA-ICOS) or off-axis CEAS (OA-CEAS), wavelength modulation off-axis CEAS (WM-OA-CEAS), off-axis phase-shift cavity enhanced absorption spectroscopy (off-axis PS-CEAS). These resonant and non-resonant cavity enhanced absorption techniques have so far not been used that frequently with TDLAS. However, since the field is developing fast, they will presumably be more used with TDLAS in the future.
=== Tip designs === Syringes come with a number of designs for the area in which the blade locks to the syringe body. Perhaps the most well known of these is the Luer lock, which simply twists the two together. Bodies featuring a small, plain connection are known as slip tips and are useful for when the syringe is being connected to something not featuring a screw lock mechanism. Similar to this is the catheter tip, which is essentially a slip tip but longer and tapered, making it good for pushing into things where there the plastic taper can form a tight seal. These can also be used for rinsing out wounds or large abscesses in veterinary use. There is also an eccentric tip, where the nozzle at the end of the syringe is not in the centre of the syringe but at the side. This causes the blade attached to the syringe to lie almost in line with the walls of the syringe itself and they are used when the blade needs to get very close to parallel with the skin (when injecting into a surface vein or artery for example).
Sources: en.wikipedia.org
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.
The original material included a linker that binds serum albumin. A later variant removed that linker to reduce the duration of action. Catalogs and papers did not consistently adopt separate names, so both remain widely labeled with the same term.
The amino acid sequence and the presence or absence of the linker group. Mass measured by spectrometry gives an independent check that separates the two forms.
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.